Daniel B. Bellissimo

2.8k total citations · 1 hit paper
46 papers, 1.7k citations indexed

About

Daniel B. Bellissimo is a scholar working on Hematology, Genetics and Genetics. According to data from OpenAlex, Daniel B. Bellissimo has authored 46 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 16 papers in Genetics and 10 papers in Genetics. Recurrent topics in Daniel B. Bellissimo's work include Platelet Disorders and Treatments (22 papers), Blood groups and transfusion (21 papers) and Blood disorders and treatments (7 papers). Daniel B. Bellissimo is often cited by papers focused on Platelet Disorders and Treatments (22 papers), Blood groups and transfusion (21 papers) and Blood disorders and treatments (7 papers). Daniel B. Bellissimo collaborates with scholars based in United States, United Kingdom and Netherlands. Daniel B. Bellissimo's co-authors include Wayne W. Grody, C. Sue Richards, Madhuri Hegde, Elaine Lyon, Soma Das, Brian E. Ward, Sherri J. Bale, Martin A. Smith, Nigel M. Crawford and Ronald W. Davis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and American Journal of Obstetrics and Gynecology.

In The Last Decade

Daniel B. Bellissimo

43 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007

2008 569 citations C. Sue Richards, Sherri J. Bale et al. Genetics in Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel B. Bellissimo United States	17	734	534	415	169	154	46	1.7k
Stéphane Bezieau France	25	438 0.6×	469 0.9×	1.1k 2.6×	242 1.4×	48 0.3×	95	2.5k
Stephan M. Tanner United States	23	539 0.7×	266 0.5×	1.4k 3.4×	279 1.7×	93 0.6×	44	2.4k
Kazumi Suzukawa Japan	24	606 0.8×	120 0.2×	705 1.7×	203 1.2×	188 1.2×	75	1.6k
Tsutomu Toki Japan	21	537 0.7×	211 0.4×	1.2k 2.9×	272 1.6×	122 0.8×	66	1.8k
M. Ueda Japan	18	495 0.7×	136 0.3×	549 1.3×	126 0.7×	176 1.1×	47	1.4k
Kerstin Westermark Sweden	26	207 0.3×	246 0.5×	462 1.1×	54 0.3×	96 0.6×	50	1.7k
Catherine Rehder United States	24	146 0.2×	601 1.1×	572 1.4×	183 1.1×	694 4.5×	75	1.9k
Nadia Jahroudi Canada	21	394 0.5×	105 0.2×	663 1.6×	79 0.5×	85 0.6×	47	1.3k
J.M. Rary United States	14	191 0.3×	537 1.0×	1.1k 2.7×	122 0.7×	91 0.6×	25	2.0k
Jacques Rochette France	20	583 0.8×	226 0.4×	474 1.1×	687 4.1×	183 1.2×	59	1.4k

Countries citing papers authored by Daniel B. Bellissimo

Since Specialization

Citations

This map shows the geographic impact of Daniel B. Bellissimo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel B. Bellissimo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel B. Bellissimo more than expected).

Fields of papers citing papers by Daniel B. Bellissimo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel B. Bellissimo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel B. Bellissimo. The network helps show where Daniel B. Bellissimo may publish in the future.

Co-authorship network of co-authors of Daniel B. Bellissimo

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel B. Bellissimo. A scholar is included among the top collaborators of Daniel B. Bellissimo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel B. Bellissimo. Daniel B. Bellissimo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aarabi, Mahmoud, et al.. (2024). Copy-number variants in the ACMG secondary finding genes: A reporting framework for clinical cytogeneticists. Genetics in Medicine Open. 2. 101839–101839.

Sadler, Brooke, Pamela A. Christopherson, Daniel B. Bellissimo, et al.. (2023). Characterization of copy-number variants in a large cohort of patients with von Willebrand disease reveals a relationship between disrupted regions and disease type. Research and Practice in Thrombosis and Haemostasis. 7(7). 102232–102232. 2 indexed citations

Yatsenko, Svetlana A., Mahmoud Aarabi, Jie Hu, et al.. (2020). Copy number alterations involving 59 ACMG ‐recommended secondary findings genes. Clinical Genetics. 98(6). 577–588. 3 indexed citations

Aarabi, Mahmoud, E Kessler, Suneeta Madan‐Khetarpal, et al.. (2018). Autism spectrum disorder in females with ARHGEF9 alterations and a random pattern of X chromosome inactivation. European Journal of Medical Genetics. 62(4). 239–242. 12 indexed citations

Flood, Veronica H., Jill M. Johnsen, Pamela A. Christopherson, et al.. (2018). Common VWF sequence variants associated with higher VWF and FVIII are less frequent in subjects diagnosed with type 1 VWD. Research and Practice in Thrombosis and Haemostasis. 2(2). 390–398. 6 indexed citations

Christopherson, Pamela A., Daniel B. Bellissimo, Veronica H. Flood, et al.. (2017). Genotype-Phenotype Relationship and the Role of Alloantibodies in Type 3 VWD in the Zimmerman Program. Blood. 130. 19–19. 3 indexed citations

Surti, Urvashi, Svetlana A. Yatsenko, Jie Hu, et al.. (2017). Maternal GRB10 microdeletion is a novel cause of cystic placenta: Spectrum of genomic changes in the etiology of enlarged cystic placenta. Placenta. 57. 33–41. 8 indexed citations

Flood, Veronica H., Pamela A. Christopherson, Daniel B. Bellissimo, et al.. (2014). Spectrum of Type 2 Von Willebrand Disease in the Zimmerman Program. Blood. 124(21). 472–472. 2 indexed citations

Flood, Veronica H., J. C. Gill, Pamela A. Christopherson, et al.. (2012). Critical von Willebrand factor A1 domain residues influence type VI collagen binding. Journal of Thrombosis and Haemostasis. 10(7). 1417–1424. 48 indexed citations

10.

Flood, Veronica H., Joan Cox Gill, Kenneth D. Friedman, et al.. (2011). von Willebrand Disease in the United States: A Perspective from Wisconsin. Seminars in Thrombosis and Hemostasis. 37(5). 528–534. 18 indexed citations

11.

Pietz, Bradley C., et al.. (2010). Molecular determination of RHD zygosity:predicting risk of hemolytic disease of the fetus and newborn related to anti‐D. Prenatal Diagnosis. 30(12-13). 1207–1212. 24 indexed citations

12.

Mast, Alan E., et al.. (2008). Behavioral, biochemical, and genetic analysis of iron metabolism in high‐intensity blood donors. Transfusion. 48(10). 2197–2204. 56 indexed citations

13.

Richards, C. Sue, Sherri J. Bale, Daniel B. Bellissimo, et al.. (2008). ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genetics in Medicine. 10(4). 294–300. 569 indexed citations breakdown →

14.

Jenkins, Carolyn, Susan T. Johnson, Daniel B. Bellissimo, & Jerome L. Gottschall. (2005). Incidence of weak D in blood donors typed as D positive by the Olympus PK 7200. Immunohematology. 21(4). 152–154. 20 indexed citations

15.

Spector, Elaine, Wayne W. Grody, Glenn E. Palomaki, et al.. (2005). Technical standards and guidelines: Venous thromboembolism (Factor V Leiden and prothrombin 20210G>A testing): A disease-specific supplement to the standards and guidelines for clinical genetics laboratories. Genetics in Medicine. 7(6). 444–453. 33 indexed citations

16.

Friedman, Kenneth D., Sandra L. Haberichter, Philip A. Kroner, et al.. (2005). Genetic mutations in von Willebrand disease identified by DHPLC and DNA sequence analysis. Molecular Genetics and Metabolism. 87(3). 262–271. 8 indexed citations

17.

Hessner, Martin J., et al.. (1997). The sensitivity of allele-specific polymerase chain reaction can obviate concern of maternal contamination when fetal samples are genotyped for immune cytopenic disorders. American Journal of Obstetrics and Gynecology. 176(2). 327–333. 12 indexed citations

18.

Garrett, Robert M., Daniel B. Bellissimo, & K.V. Rajagopalan. (1995). Molecular cloning of human liver sulfite oxidase. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1262(2-3). 147–149. 41 indexed citations

19.

Bellissimo, Daniel B. & Laura Privalle. (1995). Expression of Spinach Nitrite Reductase inEscherichia coli:Site-Directed Mutagenesis of Predicted Active Site Amino Acids. Archives of Biochemistry and Biophysics. 323(1). 155–163. 11 indexed citations

20.

Skogen, Bjøŕn, Daniel B. Bellissimo, Martin J. Hessner, et al.. (1994). Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele‐specific primers. Transfusion. 34(11). 955–960. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact